Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 91, Issue 10, Pages 1002-1007
Publisher
Wiley
Online
2016-06-30
DOI
10.1002/ajh.24465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
- (2016) Se-Il Go et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
- (2015) Nobuhiko Nakamura et al. ANNALS OF HEMATOLOGY
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2015) Thomas J. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma
- (2015) Megan V. Caram et al. LEUKEMIA & LYMPHOMA
- Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone
- (2014) Arun Ganti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics
- (2013) Carla Prado et al. Anti-Cancer Agents in Medicinal Chemistry
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) Hélène Lanic et al. LEUKEMIA & LYMPHOMA
- Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer
- (2012) Pierre Soubeyran et al. JOURNAL OF CLINICAL ONCOLOGY
- Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
- (2011) Frédéric Peyrade et al. LANCET ONCOLOGY
- Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
- (2010) A. J. Cruz-Jentoft et al. AGE AND AGEING
- Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey
- (2010) Gulistan Bahat et al. Aging Male
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
- (2010) S. Antoun et al. ANNALS OF ONCOLOGY
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now